These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34502154)

  • 1. The PPARg System in Major Depression: Pathophysiologic and Therapeutic Implications.
    Gold PW
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The organization of the stress system and its dysregulation in depressive illness.
    Gold PW
    Mol Psychiatry; 2015 Feb; 20(1):32-47. PubMed ID: 25486982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications.
    Gold PW; Gabry KE; Yasuda MR; Chrousos GP
    Endocrinol Metab Clin North Am; 2002 Mar; 31(1):37-62, vi. PubMed ID: 12055990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.
    Tsigos C; Chrousos GP
    J Psychosom Res; 2002 Oct; 53(4):865-71. PubMed ID: 12377295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences.
    Gold PW; Chrousos GP
    Proc Assoc Am Physicians; 1999; 111(1):22-34. PubMed ID: 9893154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic activation of NPFFR2 stimulates the stress-related depressive behaviors through HPA axis modulation.
    Lin YT; Liu TY; Yang CY; Yu YL; Chen TC; Day YJ; Chang CC; Huang GJ; Chen JC
    Psychoneuroendocrinology; 2016 Sep; 71():73-85. PubMed ID: 27243477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in mice.
    Alzarea S; Rahman S
    Behav Brain Res; 2019 Jul; 366():19-28. PubMed ID: 30877025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function.
    Gray JM; Wilson CD; Lee TT; Pittman QJ; Deussing JM; Hillard CJ; McEwen BS; Schulkin J; Karatsoreos IN; Patel S; Hill MN
    Psychoneuroendocrinology; 2016 Apr; 66():151-8. PubMed ID: 26821211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress, anxiety, and dendritic spines: what are the connections?
    Leuner B; Shors TJ
    Neuroscience; 2013 Oct; 251():108-19. PubMed ID: 22522470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the corticotropin-releasing hormone (CRH) neurocircuitry: Insights into post stroke functional impairments.
    Barra de la Tremblaye P; Plamondon H
    Front Neuroendocrinol; 2016 Jul; 42():53-75. PubMed ID: 27455847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullary neurones regulate hypothalamic corticotropin-releasing factor cell responses to an emotional stressor.
    Dayas CV; Buller KM; Day TA
    Neuroscience; 2001; 105(3):707-19. PubMed ID: 11516835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["Atypical" antidepressive mechanisms: glutamatergic modulation and neuroplasticity in case of tianeptine].
    András S
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):305-13. PubMed ID: 19419016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of early adverse experiences on brain structure and function: clinical implications.
    Kaufman J; Plotsky PM; Nemeroff CB; Charney DS
    Biol Psychiatry; 2000 Oct; 48(8):778-90. PubMed ID: 11063974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of hypothalamic corticotropin-releasing hormone markedly reduces anxiety behaviors in mice.
    Zhang R; Asai M; Mahoney CE; Joachim M; Shen Y; Gunner G; Majzoub JA
    Mol Psychiatry; 2017 May; 22(5):733-744. PubMed ID: 27595593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anhedonia Following Early-Life Adversity Involves Aberrant Interaction of Reward and Anxiety Circuits and Is Reversed by Partial Silencing of Amygdala Corticotropin-Releasing Hormone Gene.
    Bolton JL; Molet J; Regev L; Chen Y; Rismanchi N; Haddad E; Yang DZ; Obenaus A; Baram TZ
    Biol Psychiatry; 2018 Jan; 83(2):137-147. PubMed ID: 29033027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic innervation of the dorsal medial prefrontal cortex modulates hypothalamo-pituitary-adrenal responses to acute emotional stress.
    Radley JJ; Williams B; Sawchenko PE
    J Neurosci; 2008 May; 28(22):5806-16. PubMed ID: 18509042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased protein and mRNA expression of corticotropin-releasing factor (CRF), decreased CRF receptors and CRF binding protein in specific postmortem brain areas of teenage suicide subjects.
    Pandey GN; Rizavi HS; Bhaumik R; Ren X
    Psychoneuroendocrinology; 2019 Aug; 106():233-243. PubMed ID: 31005044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.